Medical and Pharmaceutical 60 Degrees Pharma flies after curing tick disease in small-scale study The company is planning an NDA submission for its flagship drug as a Babesiosis treatment Rowan DunneMarch 12, 2026
Medical and Pharmaceutical 60 Degrees Pharma signs patent agreement with Yale for tick disease medicine development The newly announced partnership sent shares up by 137% at the intraday peak on the Nasdaq Tuesday Rowan DunneApril 8, 2025